As of July 14, 2026, Tonix Pharmaceuticals Holding Corp. (TNXP) has a DilutionWatch DilutionScore of 53/100, rated HIGH dilution risk. Tonix Pharmaceuticals Holding Corp. has a market capitalization of $196.55M, 15.94M shares outstanding, 82 institutional holders tracked. Key dilution vectors include approximately 22 months of cash runway.
Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.
📊 Score Breakdown
🔄Convertible Debt—
🌦️ Dilution Forecast
⛈️
Warning
High probability of dilution event
30%
🔁 Convertible Conversion
60%
• Major convertible overhang: 40% potential dilution
• Convertible risk score very high (85/100)
💹 Market Data
Market Cap$196.55M
Shares Outstanding15.94M
Float15.92M
Cash$202.05M
Debt$7.49M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↑ 47.2% shares (2026Q1 vs prior)
82 institutional holders · 5.76M shares
#1
VANGUARD CAPITAL MANAGEMENT LLC
1.04M shares
#2
BlackRock, Inc.
968.2K shares
#3
CITADEL ADVISORS LLC
511.8K shares
📉 Short Interest
Short Interest3.58M
Days to Cover6.1
% of Float22.5%
FINRA data as of Jun 30, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Dec 31, 2024
xbrl
XBRL CONVERTIBLE
Dec 31, 2013
4
INSIDER TRANSACTION
Apr 01, 2026
4
INSIDER TRANSACTION
Mar 18, 2026
4
INSIDER TRANSACTION
Feb 26, 2026
Full SEC filing analysis available with free account
→
📰 Recent News
No recent news
📋 What This Means for TNXP Shareholders
Tonix Pharmaceuticals Holding Corp. (TNXP) has a DilutionScore of 53/100, placing it in the High dilution risk tier. This score reflects at least one active dilution mechanism — a shelf registration, ATM program, outstanding warrants, or limited cash runway — that could materially increase the share count over the next 12–18 months. Score as of July 14, 2026, updated from SEC EDGAR data.
DilutionWatch's EDGAR monitoring for TNXP shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.
DilutionWatch tracks over 25 SEC filing types for TNXP in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for TNXP alongside comparable high-risk stocks. Not financial advice — this analysis is for informational purposes only.
Track TNXP Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking TNXP — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
🔬 More Research for TNXP
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.